Interestingly, pharmacological and siRNA-mediated inhibition of RRM2 blocks cell proliferation, induces apoptosis and inhibits cell migration, suggesting that it may be an interesting target in ACC. This evidence concerns the gene RRM2 and adrenal cortex carcinoma.